FDA Approved: SEVELAMER CARBONATE — Original Application (Bionpharma Inc.)

View source ↗

Summary

FDA approved the original application for sevelamer carbonate from Bionpharma Inc., a generic phosphate binder for managing hyperphosphatemia in patients with c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hyperphosphatemia

Drugs mentioned

• SEVELAMER CARBONATE (sevelamer carbonate)

Snippet

ORIG AP for SEVELAMER CARBONATE (SEVELAMER CARBONATE)